World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 February 2021
Main ID:  NCT03343158
Date of registration: 10/11/2017
Prospective Registration: No
Primary sponsor: Elizabeth Glaser Pediatric AIDS Foundation
Public title: Orphans and Vulnerable Children Risk Screening Tool Research Study (Zimbabwe)
Scientific title: Orphans and Vulnerable Children Risk Screening Tool Research Study (Zimbabwe)
Date of first enrolment: October 17, 2017
Target sample size: 2260
Recruitment status: Terminated
URL:  https://clinicaltrials.gov/show/NCT03343158
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Zimbabwe
Contacts
Name:     Godfrey Woelk, PhD
Address: 
Telephone:
Email:
Affiliation:  Elizabeth Glaser Pediatric AIDS Foundation
Name:     Agnes Mahomva, MD
Address: 
Telephone:
Email:
Affiliation:  Elizabeth Glaser Pediatric AIDS Foundation
Key inclusion & exclusion criteria

Inclusion Criteria:

- Children/adolescents ages 2 up to 18 years living in a household and enrolled in
WEI/Zimbabwe and/or partners program;

- Children/adolescents ages 2 up to 18 years with HIV status unknown, or who tested
negative three or more months ago;

- Children/adolescents ages 2 up to 18 years who are healthy or ill (unless they are ill
enough to require immediate hospitalization).

Exclusion Criteria:

- Children/adolescents aged 2 up to 18 years tested HIV positive

- Children/adolescents ages 2 up to 18 years who require immediate hospitalization;

- Children/adolescents ages 2 up to 18 years who refuse/are refused participation.



Age minimum: 2 Years
Age maximum: 18 Years
Gender: All
Health Condition(s) or Problem(s) studied
Community-based
Vulnerable Children, Adolescents
Orphans, Children, Adolescents
Intervention(s)
Primary Outcome(s)
Phase 1: Validity of various questions in predicting the probability of HIV among OVC (Screening tool) [Time Frame: Four weeks]
Phase 2: Validation of combined questions in predicting HIV among OVC (Validating Screen tool) [Time Frame: Six weeks]
Secondary Outcome(s)
Usability of screening tool [Time Frame: Two weeks]
Secondary ID(s)
EG0174
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Biomedical Research and Training Institute, Zimbabwe
World Education, Inc.
United States Agency for International Development (USAID)
JSI Research & Training Institute, Inc.
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history